PT - JOURNAL ARTICLE AU - Wiysonge, Charles Shey AU - Coulson, Nancy AU - Pillay, Nirvana AU - Cooper, Sara AU - Groenewald, Candice AU - Essack, Zaynab AU - Parker, Saahier AU - Houston, Gregory AU - Simmonds, Jane AU - Jaca, Anelisa AU - Mutemwa, Muyunda AU - Katoto, Patrick DMC AU - van Rooyen, Heidi TI - Community-based Case Studies of Vaccine Hesitancy and the COVID-19 Response in South Africa; The VaxScenes Study AID - 10.1101/2022.02.21.22271272 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.21.22271272 4099 - http://medrxiv.org/content/early/2022/02/22/2022.02.21.22271272.short 4100 - http://medrxiv.org/content/early/2022/02/22/2022.02.21.22271272.full AB - Background South Africa has reported more than half of all COVID-19 cases and deaths in Africa. The South African government has launched a large COVID-19 immunization campaign with the goal of reaching more than 40 million individuals. Nonetheless, certain international, largely internet-based surveys have shown a significant proportion of vaccine hesitancy in South Africa. This study aims to determine and co-create with local stakeholders a comprehensive understanding of vaccine hesitancy and opportunities to support the promotion of other COVID-19 health-promoting behaviours at community level.Methods and design A mixed-methods, multiple case-study design; informed by the socio-ecological model of behaviour change. Four socio-economically diverse communities across South Africa will be selected and data collection will take place concurrently through three iterative phases. Phase 1 will provide insights into community experiences of COVID-19 (response) through desktop mapping exercises, observations, in-depth interviews, and focus group discussions (FGDs) designed as expression sessions with local stakeholders. Phase 2 will explore the extent and drivers of community acceptance of COVID-19 vaccines. This phase will comprise a quantitative survey based on WHO’s Behavioural and Social Drivers of Vaccination tool as well as further FGDs with community members. Phase 3 will involve cross-case study syntheses and presentation of findings to national role-players.Discussion This study will provide ground up, locally responsive, and timeous evidence on the factors influencing COVID-19 health-seeking behaviours to inform ongoing management and mitigation of COVID-19 in South Africa. It will also provide insights into the applicability of a novel vaccine hesitancy model in Africa.Competing Interest StatementThe authors have declared that no competing interests existFunding StatementThe APC is funded by the South African Medical Research Council (CSW) and the study is funded by the Human Sciences Research Council, South Africa (HvR)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study proposal was approved by the Human Research Ethics Committees of the University of the Witwatersrand in Johannesburg, South Africa (reference: H21/02/05) on 25 March 2021 the Human Sciences Research Council of South Africa (reference: REC 12/04/21) on 20 April 2021 and the South African Medical Research Council (reference: EC022-5/2021) on 27 May 2021.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableNo datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.